- Home
- ABEO vs SGC Comparison
ABEO vs SGC Comparison
Compare ABEO & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- SGC
- Stock Information
- Founded
- ABEO N/A
- SGC 1920
- Country
- ABEO United States
- SGC United States
- Employees
- ABEO N/A
- SGC N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- SGC Apparel
- Sector
- ABEO Health Care
- SGC Consumer Discretionary
- Exchange
- ABEO Nasdaq
- SGC Nasdaq
- Market Cap
- ABEO 224.3M
- SGC 281.4M
- IPO Year
- ABEO 1980
- SGC N/A
- Fundamental
- Price
- ABEO $5.04
- SGC $13.55
- Analyst Decision
- ABEO Strong Buy
- SGC Strong Buy
- Analyst Count
- ABEO 5
- SGC 2
- Target Price
- ABEO $17.00
- SGC $22.50
- AVG Volume (30 Days)
- ABEO 299.4K
- SGC 41.4K
- Earning Date
- ABEO 03-17-2025
- SGC 05-06-2025
- Dividend Yield
- ABEO N/A
- SGC 4.15%
- EPS Growth
- ABEO N/A
- SGC 79.86
- EPS
- ABEO N/A
- SGC 0.82
- Revenue
- ABEO N/A
- SGC $567,509,000.00
- Revenue This Year
- ABEO N/A
- SGC $5.29
- Revenue Next Year
- ABEO $15,721.96
- SGC $3.87
- P/E Ratio
- ABEO N/A
- SGC $16.47
- Revenue Growth
- ABEO 147.52
- SGC 4.19
- 52 Week Low
- ABEO $3.05
- SGC $11.66
- 52 Week High
- ABEO $8.87
- SGC $21.80
- Technical
- Relative Strength Index (RSI)
- ABEO 36.63
- SGC 32.87
- Support Level
- ABEO $5.02
- SGC $13.37
- Resistance Level
- ABEO $5.45
- SGC $14.02
- Average True Range (ATR)
- ABEO 0.28
- SGC 0.45
- MACD
- ABEO -0.05
- SGC -0.06
- Stochastic Oscillator
- ABEO 12.62
- SGC 10.71
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.